Related Experiment Video
Updated: Apr 10, 2026

05:35
Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
Published on: January 19, 2024
1.7K
Iron Deficiency Screening and Treatment in Hospitalized HFrEF Patients: A Quality Improvement Initiative
Enad Haddad1, Sudeep Nugooru1, Artem Oganesyan1
1Department of Internal Medicine, Jefferson Abington Hospital, Abington, Pennsylvania, USA.
JACC. Case Reports
|April 9, 2026
Summary
Implementing system-based interventions significantly improved iron deficiency screening and intravenous iron use in hospitalized heart failure patients, enhancing guideline-directed care.
Area of Science:
- Cardiology
- Internal Medicine
- Quality Improvement
Background:
- Iron deficiency is prevalent in heart failure patients, worsening symptoms and outcomes.
- Guidelines recommend screening and IV iron for heart failure with reduced ejection fraction (HFrEF), but adoption is low.
Related Concept Videos
Rheumatic Heart Disease IV: Nursing Management
457
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
457
Heart Failure VI: Adjunct Therapies
597
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
597
Renal Failure: Dose Adjustments
601
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
601

